This is not surprising since podoplanin expression is mainly detected in squamous cell cancers, CNS tumours and germinal neoplasia; in contrast, expression of podoplanin has not been found in the majority of adenocarcinomas, including lung, colon and prostate cancers [20]. This evidence concerns the gene PDPN and central nervous system neoplasm.